Maybe a step in the right direction, but when you look at the numbers, it seems like only a small step. The American Council on Science and Health (ACSH) reports on a new drug that may be useful in weight loss: New drug — Saxenda — useful for weight loss from a study using the drug. The test and control groups received daily subcutaneous injections, diet, exercise and lifestyle counselling. The results:
After 56 weeks, patients in the liraglutide group had lost a mean (±SD) of 8.0±6.7% (8.4±7.3 kg) of their body weight, whereas patients in the placebo group had lost a mean of 2.6±5.7% (2.8±6.5 kg) of their body weight
Not as much as one would hope from a drug over 56 weeks with all the other standard weight loss interventions. The results up to 0.3/lbs week are hardly observable. Perhaps it shows that the standard weight “interventions” are not that good for the populations.